INBX
Inhibrx, Inc. Common Stock
INBX
INBX
Delisted
INBX was delisted on the 29th of May, 2024.
98 hedge funds and large institutions have $548M invested in Inhibrx, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
46% less capital invested
Capital invested by funds: $1.01B → $548M (-$466M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
98
Holding in Top 10
–
Calls
$2.93M
Puts
$2K
Top Buyers
| 1 | +$23.2M | |
| 2 | +$15.3M | |
| 3 | +$11.1M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$9.75M |
| 5 |
Morgan Stanley
New York
|
+$5.08M |
Top Sellers
| 1 | -$30.8M | |
| 2 | -$25.9M | |
| 3 | -$5.21M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.71M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$2.5M |